Relapses of Anti-NMDAR, Anti-GABABR and Anti-LGI1 Encephalitis: A Retrospective Cohort Study

Risk Factors for Mortality in Anti-NMDAR, Anti-LGI1, and Anti-GABABR Encephalitis

(2022) Rui Zhong et al.   Frontiers in Immunology

Recurrence of Anti-N-Methyl-D-Aspartate Receptor Encephalitis: A Cohort Study in Central China

(2022) Jilun Feng et al.   Frontiers in Neurology

Autoimmune encephalitis: proposed best practice recommendations for diagnosis and acute management

(2021) Hesham Abboud et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Long-term Functional Outcomes and Relapse of Anti-NMDA Receptor Encephalitis

(2021) Xue Gong et al.   Neurology-Neuroimmunology & Neuroinflammation

Relapse factors of patients of anti‐N‐methyl‐D‐aspartate receptor encephalitis

(2021) Ying‐Ying Zhao et al.   ACTA NEUROLOGICA SCANDINAVICA

Seizures and risk of epilepsy in anti‐NMDAR, anti‐LGI1, and anti‐GABA B R encephalitis

(2020) Chun‐Hong Shen et al.   Annals of Clinical and Translational Neurology

Evaluation of seizure treatment in anti-LGI1, anti-NMDAR, and anti-GABABR encephalitis

(2019) Marienke A.A.M. de Bruijn et al.   NEUROLOGY

Relapse risk factors in anti‐N‐methyl‐D‐aspartate receptor encephalitis

(2019) Margherita Nosadini et al.   DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY

Anti-NMDAR encephalitis

(2019) Xiaolu Xu et al.   Neurology-Neuroimmunology & Neuroinflammation

Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis

(2018) Divyanshu Dubey et al.   ANNALS OF NEUROLOGY

Elevated LGI1-IgG CSF index predicts worse neurological outcome

(2018) Avi Gadoth et al.   Annals of Clinical and Translational Neurology

Risk Factors for Intensive Care Unit Admission in Patients with Autoimmune Encephalitis

(2017) Gayane Harutyunyan et al.   Frontiers in Immunology

A clinical approach to diagnosis of autoimmune encephalitis

(2016) Francesc Graus et al.   LANCET NEUROLOGY

Anti-LGI1–associated cognitive impairment

(2016) Helena Ariño et al.   NEUROLOGY

Anti-LGI1 encephalitis

(2016) Agnes van Sonderen et al.   NEUROLOGY

A definition and classification of status epilepticus - Report of the ILAE Task Force on Classification of Status Epilepticus

(2015) Eugen Trinka et al.   EPILEPSIA

Anti-NMDA receptor encephalitis: clinical characteristics, predictors of outcome and the knowledge gap in southwest China

(2015) W. Wang et al.   EUROPEAN JOURNAL OF NEUROLOGY

Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study

(2013) Maarten J Titulaer et al.   LANCET NEUROLOGY

Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study

(2013) Nuria Gresa-Arribas et al.   LANCET NEUROLOGY

Late-onset anti-NMDA receptor encephalitis

(2013) M. J. Titulaer et al.   NEUROLOGY

Encephalitis and GABAB receptor antibodies: Novel findings in a new case series of 20 patients

(2013) R. Hoftberger et al.   NEUROLOGY

Analysis of relapses in anti-NMDAR encephalitis

(2011) I. Gabilondo et al.   NEUROLOGY

Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis

(2010) Sarosh R. Irani et al.   ANNALS OF NEUROLOGY

N-methyl-d-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes

(2010) Sarosh R. Irani et al.   BRAIN

Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series

(2010) Meizan Lai et al.   LANCET NEUROLOGY

Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis

(2010) Josep Dalmau et al.   LANCET NEUROLOGY

Long-term effects of combined immunosuppressive treatment on myasthenic crisis

(2009) C. Rózsa et al.   EUROPEAN JOURNAL OF NEUROLOGY

Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies

(2008) Josep Dalmau et al.   LANCET NEUROLOGY